Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05471596 · ClinicalTrials.gov registry record
Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 60
- Enrollment target
NCT05471596: Completed study, sponsored by Wake Forest University Health Sciences.
NCT05471596 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05471596 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
To prospectively collect and evaluate pre-operative, intra-operative, and post-operative variables for all patients undergoing surgical microwave ablation. All patients who have a surgical microwave ablation with the Neuwave system will be added to the database after their treatment and procedures have been completed.
Primary Outcome
The primary objective is to prospectively assess the thermodynamics of microwave ablation energy in this context, specifically through the creation of power/time curves to predict future ablation volumes through single applications of MWA energy per lesion.
Interventions
- DEVICE NeuWave Microwave Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-02-14 |
| Est. Completion | 2023-11-17 |
What the finished NCT05471596 record still lists
NCT05471596 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which NeuWave Microwave Ablation System is the first listed.
NCT05471596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05471596 about?
NCT05471596 is a clinical study titled "Prospective Analysis of In Vivo Laparoscopic Microwave Ablation Thermodynamics". To prospectively collect and evaluate pre-operative, intra-operative, and post-operative variables for all patients undergoing surgical microwave ablation. All patients who have a surgical microwave ablation with the Neuwave system will be added to the database after their treatment and procedures h...
What is the current status of trial NCT05471596?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2022-02-14. Estimated completion is 2023-11-17.
What interventions are being tested in trial NCT05471596?
The interventions under investigation include: NeuWave Microwave Ablation System (DEVICE).
Who is sponsoring clinical trial NCT05471596?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI